Trials / Withdrawn
WithdrawnNCT06386289
Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic Stroke
Safety, Performance and Lesion Evaluation of Neurothrombectomy Using CEREGLIDE 92 Intermediate Catheter: A Prospective Multi-Center Single-Arm IDE Trial (SPLENDID)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Cerenovus, Part of DePuy Synthes Products, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The device is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cereglide 92 | Aspiration of cerebral large vessels occlusions |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-02-28
- Completion
- 2026-06-30
- First posted
- 2024-04-26
- Last updated
- 2025-09-02
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06386289. Inclusion in this directory is not an endorsement.